Curaleaf CEO: Cannabis Revaluation Is Coming | Trade to Black

Curaleaf CEO: Cannabis Revaluation Is Coming | Trade to Black

Insights from Curaleaf's Chairman Boris Jordan on the Cannabis Industry

Current State of Investor Interest

  • Boris Jordan highlights a limited investor pool in the cannabis sector, which shifts investments based on news and earnings but hasn't expanded significantly.
  • He emphasizes that mere uplisting to major exchanges won't drive stock value; active investor participation is crucial for growth.

Compliance and Regulatory Challenges

  • Conversations with major investment firms like BlackRock and Fidelity reveal muted interest due to lack of compliance approvals for investing in cannabis stocks.
  • Jordan believes rescheduling cannabis will be pivotal for attracting institutional investors, alongside necessary IRS and FinCEN guidance.

Anticipated Changes in Regulations

  • While optimistic about upcoming regulatory changes, he acknowledges the government's slow pace in addressing industry needs.
  • The timeline suggests potential clarity by mid-September following the July hearings, although legal challenges may arise.

Strategic Moves for Uplisting

  • Jordan discusses the importance of patience during uplisting processes to ensure fundamental business valuation rather than just market presence.
  • He notes that a strong capital structure is essential, advocating for higher institutional ownership to stabilize share volatility.

Future Growth and Market Dynamics

  • The current preference for debt over equity among institutions presents an opportunity; once equity becomes attractive, rapid growth could follow.
  • Jordan predicts inevitable consolidation within the industry as larger players seek significant investments, mirroring trends seen in other sectors.

Optimism Amidst Challenges

  • Despite previous struggles within the industry, there’s renewed excitement as companies adapt to changing market conditions post-hemp ban.
  • He stresses focusing on building solid businesses as a foundation for attracting investment rather than relying solely on market hype.

Conclusion: A Positive Outlook Ahead

  • Overall sentiment points towards gradual improvements in regulations and market dynamics leading to healthier growth prospects by 2024.
Video description

Curaleaf Holdings, Inc. (TSX: CURA | OTCQX: CURLF) Chairman and CEO Boris Jordan joined Trade To Black host Shadd Dales live from the Ignite Cannabis Capital Conference in Chicago to discuss what may be the most important phase yet for the U.S. cannabis industry. While many investors are focused on Trulieve Cannabis Corp. (NYSE: TRLV | CSE: TRUL) becoming the first major U.S. plant-touching operator to trade on a senior U.S. exchange, Boris believes the real story is what comes next: institutional capital, industry consolidation, and a broader revaluation of cannabis stocks. In this interview, Boris explains why firms like BlackRock and Fidelity are paying attention to cannabis but still require additional regulatory clarity before making meaningful equity investments. He also discusses the importance of the upcoming DEA administrative law judge hearing, potential guidance from the IRS and FinCEN, and why he believes the industry could finally be approaching a period of normalization. The conversation also covers Curaleaf’s approach to a future uplisting, why patience may be more valuable than speed, and why consolidation among leading operators such as Curaleaf Holdings, Inc. (TSX: CURA | OTCQX: CURLF), Trulieve Cannabis Corp. (NYSE: TRLV | CSE: TRUL), Green Thumb Industries Inc. (CSE: GTII | OTCQX: GTBIF), Verano Holdings Corp. (Cboe Canada: VRNO | OTCQX: VRNOF), and Glass House Brands Inc. (Cboe Canada: GLAS.A.U | OTCQX: GLASF) could be a major theme moving forward. If you’re following cannabis stocks, cannabis rescheduling, institutional investing, cannabis M&A, MSOs, or U.S. cannabis reform, this interview is worth watching. 00:00:00 Investor Participation Still Missing 00:00:50 Why Uplisting Alone Won't Work 00:01:08 What Institutions Need Before Investing 00:01:49 Schedule III Timeline & Outlook 00:03:30 Curaleaf's Uplisting Strategy 00:04:15 Building Institutional Ownership 00:05:12 Debt Investors Lead The Way 00:06:13 Cannabis Consolidation Is Coming 00:07:22 Why Boris Is Optimistic 00:08:02 Hemp Restrictions Boost Growth #CannabisStocks #Curaleaf #CURA #CURLF #CannabisInvesting #CannabisNews #ScheduleIII #CannabisRescheduling #MSOS #TradeToBlack Want to see more Cannabis Reform? 🎬 https://youtu.be/Kyq-2pNfDAo 🎬 https://youtu.be/ZGujwvR6zqQ 🎬 https://youtu.be/mM1qK4hRsi8 🎬 https://youtu.be/SUbrlKdCPOs Want to stay updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked newsletter: https://newsletter.thedalesreport.com/subscribe Find us on social media and podcast platforms: ✅ Facebook: https://www.facebook.com/TheDalesReport ✅ Twitter: https://twitter.com/TheDalesReport ✅ Instagram: https://www.instagram.com/dalesreport ✅ LinkedIn: https://www.linkedin.com/company/the-dales-report/ Apple Podcasts: https://tinyurl.com/TDRTradetoBlackonApplePodcasts Spotify: https://tinyurl.com/TDRTradeToBlackonSpotify Website: https://thedalesreport.com/ For copyright matters, contact: sdales@thedalesreport.com Podcast Disclaimer (Financial Interests) The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice. The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions. By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed. Full Disclosures: https://thedalesreport.com/website-terms-of-use/